The market leading GAG therapy¹

iAluRil is a high-dose combination therapy
used to temporarily replenish the damaged
glycosaminoglycan (GAG) layer.

iAluRil offers effective treatment of:

  • Bladder Pain Syndrome / Interstitial Cystitis
  • Radiation Cystitis (irradiation of pelvic tumours)
  • Chemical Cystitis (BCG)

And relief and prevention of:

  • Recurrent Bacterial Cystitis (rUTIs)
About iAluRil

iAluadapter®

Removing the pain of catheterisation.

Unique to iAluRil, the iAluadapter enables treatment to comfortably continue at home, without the need for a catheter.

Find out more

Organise home delivery for patients

iAluRil is available on FP10 through EPS for delivery directly to the patient’s home; providing a convenient way for patients to continue treatment at home.

Find out more

Request iAluRil or iAluadapter training

We provide HCP training on iAluRil and the iAluadapter, so get in touch if you are unsure or have any questions.

Email [email protected] for more information

Help and support

We provide a range of useful information for HCPs as well as patients; from videos on self-administration to tip sheets.

Visit our support page

UK IQVIA data (accessed December 2023)

Always read the label.

Adverse events should be reported. Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard

Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148.

IAL1010244A3_DEC2023